The Abbott Real Time HCV Genotype II test, the first genotyping test for hepatitis C patients, has received FDA approval, according to a Medscape report. The test, created by Des Plaines, Ill.-based ...
Obtaining molecular genotyping results before first-line treatment resulted in better outcomes for patients with non-small cell lung cancer, an expert explained. A recent study showed that undergoing ...
ELMWOOD PARK, N.J.--(BUSINESS WIRE)-- BioReference Laboratories, Inc. (NASDAQ: BRLI) and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts ...
It can be used to screen adults as a method to detect the disease in progeny. Osmetech received FDA clearance for its eSensor® Cystic Fibrosis Genotyping Test for use on the eSensor® XT-8 System. This ...
Screening for colorectal cancer in France: Third edition of the EDIFICE survey. Background: Irinotecan is metabolized primarily in the liver by the carboxylesterase enzyme to the SN-38 active ...
FDA this week approved its first genotyping test for patients with hepatitis C virus (HCV), Abbott’s RealTime HCV Genotype II. The test can differentiate genotypes ...
BD Onclarity™ HPV Assay is the only FDA-approved HPV assay to individually identify and report genotypes beyond 16, 18 and 45 FRANKLIN LAKES, N.J., July 22, 2020 /PRNewswire/ -- BD (Becton, Dickinson ...
The Association for Molecular Pathology (AMP) has published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of ...
The observational extended study of the previously reported 12-month randomized TAILOR-PCI trial shows genotype-guided antiplatelet therapy after percutaneous coronary intervention (PCI) did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results